Epidemiologic Study of KRAS Mutation in Brazilian Patients With Advanced or Metastatic Non Small Cell Lung Cancer
This study has been completed.
Sponsor:
AstraZeneca
Collaborator:
Laboratorio Progenetica
Information provided by:
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00956280
First received: August 10, 2009
Last updated: May 11, 2010
Last verified: May 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | April 2010 |
| Primary Completion Date: | April 2010 (Final data collection date for primary outcome measure) |